Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Walker

Showing results (291-300 of 310) with videos related to

Pageof 31
Sort By:
The Lancet. Infectious Diseases|March 9, 2024
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trialChijioke Bennett, Wayne Woo, Mark Bloch, et al.
Kidney International Supplements|March 10, 2020
Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysisLaura Sola, Nathan W Levin, David W Johnson, et al.
The Journal of Infectious Diseases|July 25, 2024
Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical TrialChijioke Bennett, E Joy Rivers, Wayne Woo, et al.
Ebiomedicine|June 21, 2016
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 TrialDaniel F Hoft, Azra Blazevic, Asmir Selimovic, et al.
Orphanet Journal of Rare Diseases|November 9, 2011
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseMaurizio Scarpa, Zsuzsanna Almássy, Michael Beck, et al.
Orphanet Journal of Rare Diseases|June 15, 2019
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
Orphanet Journal of Rare Diseases|May 31, 2019
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
Plos One|August 23, 2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locusDaniah Trabzuni, Mina Ryten, Warren Emmett, et al.
Kidney International Supplements|March 10, 2020
Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomesRoberto Pecoits-Filho, Ikechi G Okpechi, Jo-Ann Donner, et al.
Nature Reviews. Nephrology|October 16, 2025
Global landscape of kidney health across Indigenous populationsSomkanya Tungsanga, Ikechi G Okpechi, Maria Eugenia V Bianchi, et al.
Pageof 31

Showing results (291-300 of 310) with videos related to

Sort By:
Pageof 31
The Lancet. Infectious Diseases|March 9, 2024
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trialChijioke Bennett, Wayne Woo, Mark Bloch, et al.
Kidney International Supplements|March 10, 2020
Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysisLaura Sola, Nathan W Levin, David W Johnson, et al.
The Journal of Infectious Diseases|July 25, 2024
Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical TrialChijioke Bennett, E Joy Rivers, Wayne Woo, et al.
Ebiomedicine|June 21, 2016
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 TrialDaniel F Hoft, Azra Blazevic, Asmir Selimovic, et al.
Orphanet Journal of Rare Diseases|November 9, 2011
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseMaurizio Scarpa, Zsuzsanna Almássy, Michael Beck, et al.
Orphanet Journal of Rare Diseases|June 15, 2019
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
Orphanet Journal of Rare Diseases|May 31, 2019
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
Plos One|August 23, 2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locusDaniah Trabzuni, Mina Ryten, Warren Emmett, et al.
Kidney International Supplements|March 10, 2020
Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomesRoberto Pecoits-Filho, Ikechi G Okpechi, Jo-Ann Donner, et al.
Nature Reviews. Nephrology|October 16, 2025
Global landscape of kidney health across Indigenous populationsSomkanya Tungsanga, Ikechi G Okpechi, Maria Eugenia V Bianchi, et al.
Pageof 31